Company intelligence / Profile preview

Terray Therapeutics

Monrovia, California, USterraytx.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Terray is advancing its internal programs toward clinical trials with its recent Series B funding. The company has not yet published detailed clinical results.

Therapeutic areas
OtherOncologyImmunology
Modalities
Small molecules
Industry
Biotech
02

Partnerships

Gilead Sciences (December 2024)Odyssey Therapeutics (October 2024)Calico Life Sciences (October 2022)

Beyond the preview

Go deeper on Terray Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Terray Therapeutics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call